You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial
Arthritis Research & Therapy, October 2020
Tsutomu Takeuchi, Yoshiya Tanaka, Jay Erdman, Yuichiro Kaneko, Masako Saito, Chieri Higashitani, Ronald Smulders, Christopher Lademacher
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||6||19%|
|Student > Doctoral Student||2||6%|
|Student > Bachelor||2||6%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||9||29%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||10%|
|Immunology and Microbiology||2||6%|
|Agricultural and Biological Sciences||1||3%|
|Biochemistry, Genetics and Molecular Biology||1||3%|